GlassScriptPhysician profile
Caitlin N Kyle
NPI 1649654468
$2,779.68
in general payments reported to CMS, 2019-2025
12 companies · $952 in 2025
The $952 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $834 · 2023: $247 · 2024: $746 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451 · Travel and Lodging: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.07 |
| Travel and Lodging | $494.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,023.88 | 2024-2025 | Impella |
| Terumo Cardiovascular Systems Corporation | $797.73 | 2022 | |
| Medela LLC | $436.02 | 2025 | |
| Edwards Lifesciences Corporation | $164.51 | 2023 | |
| Atricure, INC. | $136.21 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Janssen Pharmaceuticals, INC | $65.97 | 2022-2023 | Xarelto |
| Pfizer INC. | $55.74 | 2024-2025 | |
| Organogenesis INC. | $38.53 | 2023 | Puraply |
| Endologix LLC | $17.34 | 2024 | Torus Stent Graft System, Endocross Device |
| Novo Nordisk INC | $15.96 | 2024 | Ozempic |
| Lemaitre Vascular, INC. | $14.21 | 2023 | Restoreflow |
| Astrazeneca Pharmaceuticals LP | $13.58 | 2025 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Kyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.